PDCD1 and neoplasm: About 12 days after tumor inoculation, when tumors reached ~ 50 mm3, mice were randomized into 4 treatment groups: HA PD-1 Ig + RT, HA PD-1 Ig, human control IgG (IgG), and RT + IgG.